103602-67-1

Basic information

• Product Name: Benzene, (9-bromononyl)-
• CAS NO: 103602-67-1
• Molecular Formula: C15H23Br
• Molecular Weight: 283.252
• Mol File: 103602-67-1.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: Benzene, (9-bromononyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzene, (9-bromononyl)-(103602-67-1)
• EPA Substance Registry System: Benzene, (9-bromononyl)-(103602-67-1)

Safety Data

• Hazardous Substances Data: 103602-67-1(Hazardous Substances Data)

Upstream product

• 4549-33-1 1,9-Dibromononane 
• 591-51-5 phenyllithium 
• 629-03-8 1 ,6-dibromohexane 
• 637-59-2 1-Bromo-3-phenylpropane 
• 3208-26-2 9-phenyl-1-hydroxynonane 
• 1663-45-2 1,2-bis-(diphenylphosphino)ethane 
• 16269-06-0 9-phenylnonanoic acid 
• 116384-96-4 5-benzylthiophen-2-butanoic acid 
• 24197-55-5 9-phenylnonanoic acid methyl ester 
• 14273-91-7 methyl 6-iodohexanoate 
• 4224-63-9 6-iodohexanoic acid 
• 117806-56-1 2-(9-Phenyl-nonyloxy)-tetrahydro-pyran 
• 100-58-3 phenylmagnesium bromide 
• 55695-90-4 2-(9-bromononyloxy)tetrahydropyran 

Downstream Products

• 71016-46-1 1,1-Dimethyl-3-[3-(9-phenyl-nonyloxy)-phenyl]-urea 
• 24065-64-3 1,18-diphenyloctadecane 
• 177706-79-5 methyl 4-oxo-13-phenyltridecanoate 
• 1353566-47-8 (R)-2-methyl-4-methylene-14-phenyl-1-((triethylsilyl)oxy)tetradecan-2-ol 
• 1353566-53-6 (R)-3,3,8,8-tetraethyl-5-methyl-5-(2-methylene-12-phenyldodecyl)-4,7-dioxa-3,8-disiladecane 
• 1353566-48-9 (R)-2-methyl-4-methylene-14-phenyl-2-((triethylsilyl)oxy)tetradecan-1-ol 
• 1353566-44-5 (R)-2-methyl-4-methylene-14-phenyl-2-((triethylsilyl)oxy)tetradecanal 
• 1353566-50-3 (2R,3R)-2-methyl-2-(2-methylene-12-phenyldodecyl)-5-oxotetrahydrofuran-3-yl acetate 
• 1353566-49-0 C₃₅H₆₄O₄Si₂ 
• 1353566-43-4 (2R,3R)-2-methyl-2-(2-methyl-12-phenyl-2-((triethylsilyl)peroxy)dodecyl)-5-oxotetrahydrofuran-3-yl acetate 
• 162559-02-6 (+)-plakortolide E 
• 1353566-51-4 (1S,4R,5R)-4-(2-hydroxy-2-methyl-12-phenyldodecyl)-4-methyl-3,6-dioxabicyclo[3.1.0]hexan-2-one 
• 1353566-52-5 C₃₀H₅₀O₄Si 
• 1353566-42-3 (4R,5R)-4-hydroxy-5-((R)-2-hydroxy-2-methyl-12-phenyldodecyl)-5-methyldihydrofuran-2(3H)-one 

Relevant articles and documents

Synthesis and glycosidase inhibition of: N-substituted derivatives of 1,4-dideoxy-1,4-imino-d-mannitol (DIM)

N-Substituted derivatives of 1,4-dideoxy-1,4-imino-d-mannitol (DIM), the pyrrolidine core of swainsonine, have been synthesized efficiently and stereoselectively from d-mannose with 2,3:5,6-di-O-isopropylidene DIM (10) as a key intermediate. These N-substituted derivatives include N-alkylated, N-alkenylated, N-hydroxyalkylated and N-aralkylated DIMs with the carbon number of the alkyl chain ranging from one to nine. The obtained 33 N-substituted DIM derivatives were assayed against various glycosidases, which allowed a systematic evaluation of their glycosidase inhibition profiles. Though N-substitution of DIM decreased their α-mannosidase inhibitory activities, some of the derivatives showed significant inhibition of other glycosidases.

Zwitterionic sulfobetaine inhibitors of squalene synthase

A substantial number of sulfobetaines (e.g., 10) have been synthesized and evaluated as inhibitors of squalene synthase (SS) on the basis of the idea that their zwitterionic structure would have properties conducive both to binding in the active site and to passage through cell membranes. When the simple sulfobetaine moiety is incorporated into compounds containing hydrophobic portions like those in farnesyl diphosphate (1) or presqualene diphosphate (2), inhibition of SS in a rat liver microsomal assay was indeed observed. For example, farnesylated sulfobetaine 10 has IC50 = 10 μM and aromatic derivative 35 has IC50 = 2 μM for SS inhibition. A wide variety of structural modifications, exemplified by compounds 43, 52, 76, 85, 91, 99, 111, and 115, was investigated. Unfortunately, no inhibitors in the submicromolar range were discovered, and exploration of a different type of zwitterion seems necessary if this appealing approach to inhibition of SS is going to provide a potential antihypercholesterolemic agent.

Enantioselective total synthesis of Irniine and Bgugaine, bioactive 2-alkylpyrrolidine alkaloids

An asymmetric total synthesis of the 2-(R)-alkylpyrrolidines, (-)-irniine (1a) and (-)-bgugaine (1b), toxic and antibiotic components of the tubers of Arisarum vulgare, and (+)-(S)-irniine (1c), was carried out by condensation of the corresponding 4-oxoalkanoic acid (9) with chiral phenylglycinol. Acids (9) were prepared from a hetero-organocuprate (I) complex, generated by reaction of methylcopper (I) with alkylmagnesium bromides and methyl chlorocarbonylpropionate. Alkaloids (1a, 1b and 1c) displayed anti Gram(+) bacterial (MIC 12.5 - 50 μg/ml) and antifungal (MIC 6.25 - 50 μg/ml) activities.